TELDAWN CH 40/12.5MG TABLET is used to manage hypertension (high blood pressure) in affected individuals when monotherapy with chlorthalidone or telmisartan becomes inadequate to control the condition. It is also used as initial therapy in patients who are indicated for multiple drug therapy to control high blood pressure. It is a combination of Chlorthalidone and Telmisartan which belongs to the group of medicines called Diuretics and Angiotensin II receptor blockers, respectively.

TELDAWN CH 40/12.5MG TABLET is not recommended for use in patients who are allergic to chlorthalidone, telmisartan, and/or any sulphonamide-derived medicines. It is also not recommended for use in patients suffering from anuria and severe liver impairment. Before taking the medicine, inform your doctor if you have liver problems, kidney problems and/or heart problems (such as congestive heart failure).

TELDAWN CH 40/12.5MG TABLET is not recommended for use during pregnancy and in women planning for pregnancy. It is also not recommended for use in breastfeeding women since it passes through breast milk. It should be used with caution in children and adolescents (aged 6 to 18 years) and in elders (aged 65 years and above). The most common side effects are back pain, sore throat, nausea, abdominal pain, indigestion, diarrhoea, and/or headache. Consult your doctor if any of these symptoms worsen.